Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.
about
Liver steatosis in hepatitis C patientsFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVHepatitis C virus infection in the human immunodeficiency virus infected patient.Mechanisms of alcohol-mediated hepatotoxicity in human-immunodeficiency-virus-infected patients.Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunodeficiency virus mono-infected patients.Adipokines, cytokines and body fat stores in hepatitis C virus liver steatosis.Serum sclerostin in hepatitis C virus infected patients.Pilot study of pioglitazone before HCV retreatment in HIV/HCV genotype 1-infected subjects with insulin resistance and previous nonresponse to peginterferon and ribavirin therapy: A5239.Antiviral drugs and the treatment of hepatitis C.Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine.Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV-infected patients.Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients.Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.Iron and proinflammatory cytokines in chronic hepatitis C virus infection.Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients.Reliability and agreement studies: a guide for clinical investigators.Return-to-health effect of modern combined antiretroviral therapy potentially predisposes HIV patients to hepatic steatosis.Human immunodeficiency virus and liver disease: A comprehensive update.Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
P2860
Q27010631-A8C066FB-5AA8-48D6-98F0-DAB1CA9DB3F7Q28079826-35823D0B-ACB4-4E98-8308-347322586A06Q34168504-E7310475-759B-4BD5-9615-90CA44D89571Q35012716-B1F223AB-2E56-44EB-AD4D-4DE8F235B12EQ35628262-52440FD3-2D9C-4494-BE78-A63766DC4B6AQ36442586-7349EA50-8619-46A2-85F7-23829015A146Q37673471-4BA63EE7-E55B-41B7-A0A4-3A32950CFBA3Q37720828-759BD928-15C8-4B96-B02A-8E742E4BE090Q37987057-A2997D1F-8D2C-4BDE-BDFF-7A8DD6BED275Q38614025-2886346E-4477-43DE-9891-E70C1951A318Q39726931-218794A0-969C-4A32-91C0-6FCDE5AA6F54Q39877513-D6FFCF52-8118-4659-8422-F34C2E132619Q40360505-8BE663DE-DCB5-4414-815A-4F916F87043EQ42213984-E6182D33-8A36-44F7-85BB-782424DA7C77Q42280936-D20BA0C5-DBEC-427F-853B-EE92060D1341Q45358296-845557A2-6951-43B1-AD44-5932CE3C5C70Q50931699-AFB9E459-EF9D-4A35-8DC7-BF4D270F2F0DQ54226681-E72AD155-6F95-46AF-A679-502BF2027816Q55109199-664379CE-613F-470A-9F42-8C4CB2CE35CDQ56920945-1182640B-D14A-40CC-A3CB-D9723A039AF7
P2860
Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@ast
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@en
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@nl
type
label
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@ast
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@en
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@nl
prefLabel
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@ast
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@en
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@nl
P2093
P2860
P1433
P1476
Incidence and risk factors for ...... ith HIV and hepatitis C virus.
@en
P2093
Catherine G Sutcliffe
David L Thomas
Mark S Sulkowski
Michael S Torbenson
Richard D Moore
Shruti H Mehta
Tinsay A Woreta
Todd T Brown
Yvonne Higgins
P2860
P304
P356
10.1053/J.GASTRO.2010.11.052
P407
P577
2010-12-04T00:00:00Z